{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-05",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "45802-499",
      "generic_name": "Alogliptin Benzoate and Pioglitazone hydrochloride",
      "labeler_name": "Padagis Israel Pharmaceuticals Ltd",
      "brand_name": "Alogliptin and Pioglitazone",
      "active_ingredients": [
        {
          "name": "ALOGLIPTIN BENZOATE",
          "strength": "25 mg/1"
        },
        {
          "name": "PIOGLITAZONE HYDROCHLORIDE",
          "strength": "45 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "45802-499-65",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (45802-499-65)",
          "marketing_start_date": "20160408",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Padagis Israel Pharmaceuticals Ltd"
        ],
        "rxcui": [
          "1368410",
          "1368424",
          "1368431",
          "1368438"
        ],
        "spl_set_id": [
          "642b1e90-701e-42f2-bac6-a4918738e2c9"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0345802260659",
          "0345802402653",
          "0345802351654",
          "0345802499653"
        ],
        "unii": [
          "JQT35NPK6C",
          "EEN99869SC"
        ]
      },
      "marketing_category": "NDA AUTHORIZED GENERIC",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "11c471e0-6c64-4f13-b6ed-d2c80bc89f20",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20160408",
      "product_id": "45802-499_11c471e0-6c64-4f13-b6ed-d2c80bc89f20",
      "application_number": "NDA022426",
      "brand_name_base": "Alogliptin and Pioglitazone",
      "pharm_class": [
        "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
        "Dipeptidyl Peptidase 4 Inhibitors [MoA]",
        "Peroxisome Proliferator Receptor alpha Agonist [EPC]",
        "Peroxisome Proliferator Receptor gamma Agonist [EPC]",
        "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]",
        "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]",
        "Thiazolidinedione [EPC]",
        "Thiazolidinediones [CS]"
      ]
    }
  ]
}